All lobbying filings

The McManus Group

The McManus Group filed a Q2 report for Grail, Inc. on July 20, 2026, reporting $50,000 in lobbying income.

Lobbying for Grail, Inc. · Biotechnology services

As filed: THE MCMANUS GROUP for GRAIL, INC.

All filings by The McManus Group · Everything Grail, Inc. has reported

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 20, 2026

Income

$50,000

What the client paid this registrant for the period.

Client based in

District of Columbia

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Medicare/Medicaid

Medicare issues as they relate to oncology and multi-cancer early detection, including diagnostics and screening.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.